Progress in the management and treatment of infected pancreatic necrosis

被引:23
作者
Farkas, G
Márton, J
Mándi, Y
Szederkényi, E
Balogh, A
机构
[1] Albert Szent Gyorgyi Med Univ, Dept Surg, H-6701 Szeged, Hungary
[2] Albert Szent Gyorgyi Med Univ, Inst Microbiol, H-6701 Szeged, Hungary
关键词
Candida infection; cytokine production; infected pancreatic necrosis; pancreatitis; pentoxifylline; surgical management;
D O I
10.1080/003655298750026534
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Infected pancreatic necrosis and sepsis are the leading causes of mortality in necrotizing pancreatitis. A review has been undertaken of the results of the past two decades relating to different surgical treatments of infected pancreatic necrosis. During the period 1978-85, the surgical treatment of necrotizing pancreatitis and its complications in our department consisted of the 'conventional' therapy (resection of the involved pancreatic tissue, or necrosectomy and drainage) in 61 patients, with a mortality rate of 36% (22 patients died). Since 1986, we have performed necrosectomy and other surgical interventions combined with continuous widespread lavage in 142 patients with infected pancreatic necrosis. The overall mortality decreased significantly to 6.3% (9 patients died). This result was achieved by means of aggressive surgical treatment, continuous, prolonged washing and suction drainage and supportive therapy, including immunonutrition, modifying the cytokine production and adequate antibiotic and antifungal medication. This surgical strategy provides the possibility for recovery in cases of necrotizing pancreatitis with septic complications.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 49 条
[31]  
LARVIN M, 1989, LANCET, V2, P201
[32]   DEBRIDEMENT AND CLOSED CAVITY IRRIGATION FOR THE TREATMENT OF PANCREATIC NECROSIS [J].
LARVIN, M ;
CHALMERS, AG ;
ROBINSON, PJ ;
MCMAHON, MJ .
BRITISH JOURNAL OF SURGERY, 1989, 76 (05) :465-471
[33]   ELEVATION OF SERUM INTERLEUKIN-6 CONCENTRATION PRECEDES ACUTE-PHASE RESPONSE AND REFLECTS SEVERITY IN ACUTE-PANCREATITIS [J].
LESER, HG ;
GROSS, V ;
SCHEIBENBOGEN, C ;
HEINISCH, A ;
SALM, R ;
LAUSEN, M ;
RUCKAUER, K ;
ANDREESEN, R ;
FARTHMANN, EH ;
SCHOLMERICH, J .
GASTROENTEROLOGY, 1991, 101 (03) :782-785
[34]  
MADRY S, 1994, J AM COLL SURGEONS, V178, P277
[35]  
Mandi Y, 1996, IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL I, P420
[36]   INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION AND ICAM-1 EXPRESSION BY PENTOXIFYLLINE - BENEFICIAL-EFFECTS IN SEPSIS SYNDROME [J].
MANDI, Y ;
FARKAS, G ;
OCSOVSZKY, I ;
NAGY, Z .
RESEARCH IN EXPERIMENTAL MEDICINE, 1995, 195 (05) :297-307
[37]  
McKay C., 1992, Digestion, V52, P104
[38]  
PEDERZOLI P, 1990, SURG GYNECOL OBSTET, V170, P197
[39]  
PEDERZOLI P, 1989, GASTROENTEROLOGY, V96, P1389
[40]  
RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69